{{위키데이터 속성 추적}}
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 464373286
| IUPAC_name = [(2,3-Dihydro-1,5-dimethyl-3-oxo-2-phenyl-1''H''-pyrazol-4-yl)methylamino] methanesulfonic acid
| image =Metamizole2DACS.svg
| image2 =Metamizole monohydrate 3D ball-and-stick.png
| width2 = 250px
| synonyms = Dipyrone ([[British Approved Name|BAN]] {{abbr|UK|United Kingdom}}, [[United States Adopted Name|USAN]] {{abbr|US|United States}})

<!--Clinical data-->
| tradename =  Novalgin,<ref name=Brune/> others<ref name=drugsInternational/>
| Drugs.com = {{drugs.com|international|metamizole}}
| routes_of_administration = Oral, IM, IV, rectal
| pregnancy_category = None assigned; no evidence of [[teratogen]]icity in animal studies, but use in the third trimester may cause adverse effects in the newborn or [[ductus arteriosus]] (a heart defect) due to its weak NSAID activity.<ref name="MD">{{웹 인용|title=Dipyrone |work=Martindale: The Complete Drug Reference |publisher=Pharmaceutical Press |date=13 December 2013 |access-date=19 April 2014 |url=http://www.medicinescomplete.com/mc/martindale/current/2638-f.htm |veditors = Brayfield A }}</ref><ref name="SPC">{{웹 인용|title=Fachinformation (Zusammenfassung der Merkmale des Arzneimittels) Novaminsulfon injekt 1000 mg Lichtenstein Novaminsulfon injekt 2500 mg Lichtenstein|url=https://www.zentiva.de/-/media/files/zentivade/produkte/novaminsulfon-lichtenstein/_de_gif_novaminsulfon_injekt_2500mg.pdf|language=독일어|date=February 2013|access-date=19 April 2014|work=Winthrop Arzneimittel GmbH|publisher=Zinteva Pharm GmbH}}</ref>
| legal_status = Over-the-counter (some countries, see text); prescription-only (others); withdrawn (others)
<!--Pharmacokinetic data-->
| bioavailability = 100% (active metabolites)<ref name="deranaes2008">{{저널 인용| vauthors = Jage J, Laufenberg-Feldmann R, Heid F | title = [Drugs for postoperative analgesia: routine and new aspects. Part 1: non-opioids] | language = 독일어 | journal = Der Anaesthesist | volume = 57 | issue = 4 | pages = 382–90 | date = April 2008 | pmid = 18351305 | doi = 10.1007/s00101-008-1326-x | trans-title = Drugs for postoperative analgesia: routine and new aspects. Part 1: non-opioids }}</ref>
| protein_bound = 48–58% (active metabolites)<ref name = deranaes2008/>
| metabolism = Liver<ref name = deranaes2008/>
| elimination_half-life = 14 minutes (parent compound; parenteral);<ref name = SPC/> metabolites: 2–4 hours<ref name = deranaes2008/>
| excretion = Urine (96%, IV; 85%, oral), faeces (4%, IV).<ref name = SPC/>
<!--Identifiers-->
| index_label = 
| index2_label =
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 50567-35-6
| CAS_supplemental = <br>68-89-3 (sodium salt)
| ATC_prefix = N02
| ATC_suffix = BB02
| PubChem = 3111
| PubChem2 = 522325 <!-- sodium salt -->
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB04817 <!-- sodium salt -->
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 3000
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 934T64RMNJ
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 62088
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 461522
<!--Chemical data-->
| C=13 | H=17 | N=3 | O=4 | S=1
| smiles = c1ccccc1N2N(C)C(C)=C(C2=O)N(C)CS(=O)(=O)O
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C13H17N3O4S/c1-10-12(14(2)9-21(18,19)20)13(17)16(15(10)3)11-7-5-4-6-8-11/h4-8H,9H2,1-3H3,(H,18,19,20)
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = LVWZTYCIRDMTEY-UHFFFAOYSA-N
}}
'''설피린'''(sulpyrin), '''메타미졸'''은 [[해열제]]와 [[진통제]] 성분으로 사용되는 [[피린]]계 약제이다.

== 각주 ==
{{각주}}

{{전거 통제}}
{{토막글|의학}}

[[분류:의약품]]
[[분류:작용 기전이 알려지지 않은 약]]
[[분류:시장에서 철퇴된 약]]
[[분류:설폰산염]]
[[분류:피라졸론]]